902.96KMarket Cap0.00P/E (TTM)
0.010High0.009Low485.82KVolume0.009Open0.010Pre Close4.45KTurnover0.48%Turnover Ratio0.18P/E (Static)100.33MShares0.25052wk High-0.01P/B902.93KFloat Cap0.00652wk Low--Dividend TTM100.33MShs Float23550.000Historical High--Div YieldTTM10.31%Amplitude0.006Historical Low0.009Avg Price1Lot Size
Evofem Biosciences Stock Forum
Benzinga· 8 mins ago
As the popularity of GLP-1 receptor agonists continues to surge in the treatment of obesity and type 2 diabetes, Evofem Biosciences, Inc. (OTCQB:EVFM) is raising awareness of the potential impact these medications may have on the effectiveness of oral contraceptives. With an increasing number of women turning ...
Evofem Announces Issuance of New U.S. Patent Covering Phexxi Composition of Matter
$Evofem Biosciences (EVFM.US)$ stock experienced a significant surge, doubling its value today, catching attention in the micro-cap stocks category. Despite its niche focus on women's health products, EVFM's long-term chart has been unimpressive, trending towards zero.
Market Capitalization and Acquisition Offer:
The company currently trades at a market capitalization of only $1.4 million. Surprisingly, Evofem received an acquisition offer from $Aditxt (ADTX.US)$ valued at...
No comment yet